Skip to main content
. 2021 Dec 13;12:781789. doi: 10.3389/fphys.2021.781789

TABLE 3.

Crude and adjusted models used to assess the association between the serum FABP4 and liver steatosis.

Group All
Diabetes
Obesity
Metabolic syndrome
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Crude 1.04 (1.02–1.05) <0.001 1.03 (1.01–1.05) 0.001 1.04 (1.00–1.09) 0.069 1.02 (1.00–1.03) 0.048
Model 1 1.06 (1.04–1.08) <0.001 1.05 (1.03–1.08) <0.001 1.08 (1.01–1.14) 0.016 1.05 (1.02–1.07) <0.001
Model 2 1.04 (1.02–1.07) <0.001 1.04 (1.02–1.07) 0.001 1.08 (1.00–1.17) 0.041 1.04 (1.01–1.06) 0.003

Logistic regression models (odds ratio; OR and 95% confidence interval; CI). Model 1 was adjusted by age and gender, and Model 2 was adjusted by age, gender, glucose, triglycerides, apoA1, apoB100, and AST (METHOD = Enter).0.001 vs FLI < 60 individuals.